Gilead has set the price at $390 per vial in developed countries, or $2,340 for six vials used over the...
An acquisition of Immunomedics would add to several deals Gilead inked this year with the aim of expanding...
The US government trial in April showed that patients given remdesivir recovered 31% faster than those...
Physicians can prescribe the drug in Europe once the European Commission gives its approval
Around 70% of patients who received remdesivir for 10 days showed improvement
The clinical trial is due to begin in early June with approximately 450 patients participating
Copyright Ⓒ 2012-2019. 2A Media Limited.
All Rights Reserved.
8/C, FR Tower, Panthapath, Dhaka 1207, Bangladesh.
Kazi Anis Ahmed, Publisher